Catherine C. Turkel - 09 Feb 2023 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Issuer symbol
LEXX
Transactions as of
09 Feb 2023
Net transactions value
+$4,267
Form type
4
Filing time
27 Feb 2023, 09:52:10 UTC
Previous filing
13 Oct 2022
Next filing
25 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX Common Shares Purchase $4,267 +1,500 $2.84 1,500 09 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 3,400 09 Feb 2023 Common Shares 3,400 $3.04 Direct
holding LEXX Stock Options 5,000 09 Feb 2023 Common Shares 1,600 $1.96 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.